Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Acquisitions & Divestments (2017 - 2025)

Historic Change in Acquisitions & Divestments for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $27.3 million.

  • Puma Biotechnology's Change in Acquisitions & Divestments rose 6714.19% to $27.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.1 million, marking a year-over-year increase of 4128.76%. This contributed to the annual value of $55.8 million for FY2024, which is 22229.92% up from last year.
  • Latest data reveals that Puma Biotechnology reported Change in Acquisitions & Divestments of $27.3 million as of Q3 2025, which was up 6714.19% from $10.7 million recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Change in Acquisitions & Divestments ranged from a high of $27.3 million in Q3 2025 and a low of -$37000.0 during Q4 2022
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $8.5 million (2022), whereas its average is $9.5 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first tumbled by 10080.07% in 2022, then soared by 868648.65% in 2023.
  • Puma Biotechnology's Change in Acquisitions & Divestments (Quarter) stood at $4.6 million in 2021, then crashed by 100.8% to -$37000.0 in 2022, then skyrocketed by 8686.49% to $3.2 million in 2023, then surged by 308.25% to $13.0 million in 2024, then skyrocketed by 110.61% to $27.3 million in 2025.
  • Its last three reported values are $27.3 million in Q3 2025, $10.7 million for Q2 2025, and $14.1 million during Q1 2025.